Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jul 29, 2025 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Oncolytics Biotech (ONCY) filed a 6-K on 7/29/25, standard foreign issuer report.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on July 29, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved in the Pharmaceutical Preparations industry. This filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing indicates ongoing reporting requirements for Oncolytics Biotech Inc. as a foreign private issuer, providing transparency to investors about its regulatory status.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- July 2025 (date) — Reporting period
- 20250729 (date) — Filing date
- Calgary, Alberta, Canada (location) — Company headquarters
- 001-38512 (other) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K filing is a report of foreign private issuers required by the SEC, used to furnish information that the issuer would be required to make public in its home country or that it has made or will make public to its security holders.
When was this specific Form 6-K filed by Oncolytics Biotech Inc.?
This Form 6-K was filed on July 29, 2025.
What is Oncolytics Biotech Inc.'s primary business classification according to the filing?
Oncolytics Biotech Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Does Oncolytics Biotech Inc. file annual reports under Form 20-F or 40-F?
According to the filing, Oncolytics Biotech Inc. files annual reports under Form 20-F.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 29, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).